|
|
|||||||||
(Pediatrics in Review. 2007;28:75-77.)
© 2007 American Academy of Pediatrics
In Brief |
| The first 20% of the full text of this article appears below. |
Acute Renal Failure Associated with Non-Steroidal Anti-Inflammatory Drugs in Healthy Children. Krause I, Cleper R, Einstein B, Davidovits M.
Pediatr Nephrol. 2005;20
:1295
–1298[CrossRef][Medline]
Analgesic-antipyretic and Anti-inflammatory Agents and Drugs Employed in the Treatment of Gout. In: Hardman JG, Limbird LE, Gilman AG, eds.
Goodman & Gilmans The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001:687
–731
Non-steroidal Anti-inflammatory Drugs and Exacerbations of Asthma in Children. Body R, Potier K.
Emerg Med J. 2004;21
:713
–724
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a chemically heterogeneous group of compounds that have analgesic, antipyretic, and anti-inflammatory properties. These effects are mediated primarily through inhibition of the cyclooxygenase enzymes (COX-1 and COX-2), which are involved in the production of prostaglandins (PGs) and thromboxanes (TXs). The COX-1 isoform is produced constitutively in a variety of tissues and organs, including the kidney, vascular endothelium, and gastric mucosa. In many tissues, expression of the COX- 2 isoform is induced by inflammatory mediators, but COX-2 also is produced constitutively in the brain, uterus, and kidneys.
PGI2 and prostaglandins of the E family (PGEs) reduce the pain threshold of nociceptors, resulting in hyperalgia (the sensitization of afferent nerve endings to the effects of mechanical or chemical stimulation). Hence, NSAID-mediated inhibition of PGI2 and PGE synthesis can provide effective
Read all Rapid Responses
David N. Collier, MD, PhD
Brody School of Medicine at East Carolina University
Greenville, NC
Cassie Billings, PharmD
Pitt County Memorial Hospital
Greenville, NC
Janet R. Serwint, MD, Consulting Editor, In Brief
Rapid Responses:
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |